Wearables & CGM
Consumer wearables now generate continuous streams of physiologically meaningful data — HRV, sleep architecture, skin temperature, and interstitial glucose — that were previously only available in clinical research settings. The critical question is not whether to track, but which platforms track the right variables with sufficient accuracy to inform decisions. This comparison focuses on four platforms with published validation data and distinct use cases for longevity-focused users.
Educational ranking only. Not medical advice. Evidence grade refers to published human research on this ingredient — not proof that any specific product treats or prevents disease. Affiliate links may generate revenue but never affect ratings.
Oura Ring (Gen 3)
The Oura Ring Gen 3 achieves the highest sleep-staging accuracy of any consumer wearable currently validated against polysomnography (PSG). De Zambotti et al. (Sleep Medicine, 2019) validated sleep-stage detection against lab PSG, finding strong concordance for REM, light, and deep sleep classification. HRV readings are within 2% of ECG in resting-state conditions. The ring form factor — combined with a 20-minute charge cycle and 24/7 wear comfort — produces the lowest data-gap rate of any reviewed platform. The readiness score synthesizes HRV, sleep duration, sleep quality, and skin temperature deviation into a single daily signal that reflects parasympathetic recovery status.
Whoop 4.0
Whoop 4.0 is the platform most purpose-built for athletic load management. HRV accuracy in resting state is comparable to Oura. The proprietary strain algorithm — validated in elite sports contexts including professional cycling and NBA training staff deployments — quantifies cumulative cardiovascular load on a 0–21 scale and compares it against recovery capacity. The sleep performance score tracks rolling sleep debt, which is directly actionable for training schedule decisions. Skin conductance measurement adds a stress-load layer not available in ring-form devices. The screenless wristband with on-wrist charging eliminates daily removal interruptions that create data gaps in conventional smartwatch designs.
Apple Watch Series 9 / Ultra
Apple Watch holds the strongest cardiovascular surveillance credentials of any consumer wearable. The Apple Heart Study (Perez et al., NEJM 2019; n=419,297) validated irregular heart rhythm notification for AFib with 98.3% sensitivity and 99.6% specificity against gold-standard ECG confirmation — the largest smartwatch validation study published to date. The single-lead ECG is FDA-cleared for AFib classification. Fall detection, crash detection, and emergency SOS add safety utility beyond biometric tracking. Sleep staging is less accurate than Oura, and the 18–36 hour battery requires daily charging, which creates nightly data gaps if worn consistently. Temperature sensing is available on Ultra 2 only.
Levels Health (CGM)
Levels Health is a continuous glucose monitoring (CGM) platform built on the Dexcom G7 sensor, which reads interstitial glucose every 5 minutes, 24 hours a day. The Dexcom G7 carries FDA clearance for glycemic monitoring and meets the ±9% mean absolute relative difference (MARD) accuracy standard required for clinical CGM use. Levels translates raw glucose data into meal scores, sleep glucose tracking, and activity impact analysis. Continuous monitoring reveals postprandial glucose spikes from specific foods that standard fasting glucose and HbA1c tests miss entirely — a significant insight for longevity-focused users who eat foods that appear metabolically neutral on standard labs but drive measurable glycemic variability.
One research-grounded briefing per week. No hype, no affiliate push, no AI-generated filler.
Educational ranking only. Not medical advice. Evidence grade refers to published human research on this platform — not proof that any specific device diagnoses or prevents disease. Accuracy data is from published validation studies and may not reflect all use conditions.